Literature DB >> 35858246

Transcriptomic responses are sex-dependent in the skeletal muscle and liver in offspring of obese mice.

Amy C Kelly1, Fredrick J Rosario1, Jeannie Chan2, Laura A Cox2, Theresa L Powell1,3, Thomas Jansson1.   

Abstract

Infants born to obese mothers are more likely to develop metabolic disease, including glucose intolerance and hepatic steatosis, in adult life. We examined the effects of maternal obesity on the transcriptome of skeletal muscle and liver tissues of the near-term fetus and 3-mo-old offspring in mice born to dams fed a high-fat and -sugar diet. Previously, we have shown that male, but not female, offspring develop glucose intolerance, insulin resistance, and liver steatosis at 3 mo old. Female C57BL6/J mice were fed normal chow or an obesogenic high-calorie diet before mating and throughout pregnancy. RNAseq was performed on the liver and gastrocnemius muscle following collection from fetuses on embryonic day 18.5 (E18.5) as well as from 3-mo-old offspring from obese dams and control dams. Significant genes were generated for each sex, queried for enrichment, and modeled to canonical pathways. RNAseq was corroborated by protein quantification in offspring. The transcriptomic response to maternal obesity in the liver was more marked in males than females. However, in both male and female offspring of obese dams, we found significant enrichment for fatty acid metabolism, mitochondrial transport, and oxidative stress in the liver transcriptomes as well as decreased protein concentrations of electron transport chain members. In skeletal muscle, pathway analysis of gene expression revealed sexual dimorphic patterns, including metabolic processes of fatty acids and glucose, as well as PPAR, AMPK, and PI3K-Akt signaling pathways. Transcriptomic responses to maternal obesity in skeletal muscle were more marked in female offspring than males. Female offspring had greater expression of genes associated with glucose uptake, and protein abundance reflected greater activation of mTOR signaling. Skeletal muscle and livers in mice born to obese dams had sexually dimorphic transcriptomic responses that changed from the fetus to the adult offspring. These data provide insights into mechanisms underpinning metabolic programming in maternal obesity.NEW & NOTEWORTHY Transcriptomic data support that fetuses of obese mothers modulate metabolism in both muscle and liver. These changes were strikingly sexually dimorphic in agreement with published findings that male offspring of obese dams exhibit pronounced metabolic disease earlier. In both males and females, the transcriptomic responses in the fetus were different than those at 3 mo, implicating adaptive mechanisms throughout adulthood.

Entities:  

Keywords:  RNA; fetal development; fetal programming; insulin resistance; sequence analysis

Mesh:

Substances:

Year:  2022        PMID: 35858246      PMCID: PMC9529275          DOI: 10.1152/ajpendo.00263.2021

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   5.900


  78 in total

1.  Epidemiologic evidence for the fetal overnutrition hypothesis: findings from the mater-university study of pregnancy and its outcomes.

Authors:  Debbie A Lawlor; George Davey Smith; Michael O'Callaghan; Rosa Alati; Abdullah A Mamun; Gail M Williams; Jake M Najman
Journal:  Am J Epidemiol       Date:  2006-12-07       Impact factor: 4.897

2.  Pregnancy complications and outcomes among overweight and obese nulliparous women.

Authors:  J M Baeten; E A Bukusi; M Lambe
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

3.  Obesity induced by cafeteria feeding and pregnancy outcome in the rat.

Authors:  Asli Akyol; Simon C Langley-Evans; Sarah McMullen
Journal:  Br J Nutr       Date:  2009-07-22       Impact factor: 3.718

4.  Maternal obesity at conception programs obesity in the offspring.

Authors:  Kartik Shankar; Amanda Harrell; Xiaoli Liu; Janet M Gilchrist; Martin J J Ronis; Thomas M Badger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-11-21       Impact factor: 3.619

5.  Activation of placental insulin and mTOR signaling in a mouse model of maternal obesity associated with fetal overgrowth.

Authors:  Fredrick J Rosario; Theresa L Powell; Thomas Jansson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-21       Impact factor: 3.619

Review 6.  Maternal Obesity, Maternal Overnutrition and Fetal Programming: Effects of Epigenetic Mechanisms on the Development of Metabolic Disorders.

Authors:  Ezgi Şanlı; Seray Kabaran
Journal:  Curr Genomics       Date:  2019-09       Impact factor: 2.236

7.  Programming effects of maternal and gestational obesity on offspring metabolism and metabolic inflammation.

Authors:  E Chang; H Hafner; M Varghese; C Griffin; J Clemente; M Islam; Z Carlson; A Zhu; L Hak; S Abrishami; B Gregg; K Singer
Journal:  Sci Rep       Date:  2019-11-05       Impact factor: 4.379

8.  Maternal Western-style high fat diet induces sex-specific physiological and molecular changes in two-week-old mouse offspring.

Authors:  Mona Mischke; Maurien G M Pruis; Mark V Boekschoten; Albert K Groen; Aditia R Fitri; Bert J M van de Heijning; Henkjan J Verkade; Michael Müller; Torsten Plösch; Wilma T Steegenga
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

9.  Effects of lifestyle intervention on dietary intake, physical activity level, and gestational weight gain in pregnant women with different pre-pregnancy Body Mass Index in a randomized control trial.

Authors:  Amy Leung Hui; Lisa Back; Sora Ludwig; Phillip Gardiner; Gustaaf Sevenhuysen; Heather J Dean; Elisabeth Sellers; Jonathan McGavock; Margaret Morris; Depeng Jiang; Garry X Shen
Journal:  BMC Pregnancy Childbirth       Date:  2014-09-24       Impact factor: 3.007

10.  Maternal Exercise Improves Glucose Tolerance in Female Offspring.

Authors:  Kristin I Stanford; Hirokazu Takahashi; Kawai So; Ana Barbara Alves-Wagner; Noah B Prince; Adam C Lehnig; Kristen M Getchell; Min-Young Lee; Michael F Hirshman; Laurie J Goodyear
Journal:  Diabetes       Date:  2017-06-01       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.